November 1, 2004, London, U.K. — Ogilvy Public Relations Worldwide has appointed Philly Jones to head the Health and Medical Practice in the UK based at the agency’s European HQ in Canary Wharf.
Most recently, Philly led Ruder Finn’s Global Healthcare business in New York where she spent seven years building the business. Prior to her spell in the US, Philly worked for Ruder Finn in London, Edelman UK and Shire Health.
During her time with Ruder Finn in the US, Philly was responsible for creating and implementing brand marketing and PR programmes for Pfizer’s Viagra, Schering-Plough’s Pegylated Interferon, and for Novartis on Zometa, Exjade, Zelnorm and all brands within the Transplantation and Immunology Franchise.
Philly Jones said: “I’m excited to have the opportunity to work in such a creative environment as Ogilvy PR. I look forward to working with their dynamic team of people to push the boundaries of the future healthcare PR campaigns”.
Paul Barber, Chief Executive, EMEA, Ogilvy Public Relations, said: “Philly is a fantastic addition to our team. She is vastly experienced and hugely respected in the healthcare PR sector – both here in the UK and in the US. We look forward to building our health and medical business across the region with Philly at the helm.
“Philly replaces Jeannine Nolan, who has been acting Head of Practice in the UK office for the past six months. Jeannine, who is a long-term freelancer, has done a great job working with the team during this transitional period. Her skill set was particularly helpful to Ogilvy during this time. We wish her every success in the future”.
Philly Jones will join Ogilvy PR’s UK Board and takes up her appointment on November 1, 2004.
About Ogilvy Public Relations Worldwide
Ogilvy Public Relations Worldwide is a global marketing communications firm, with offices in more than 60 cities around the world. Entering its 24th year providing public relations solutions, Ogilvy Public Relations Worldwide has specialties in consumer marketing, corporate (B2B), health & medical, social marketing, technology, public affairs, government relations and entertainment. Through its subsidiary Feinstein Kean Healthcare, Ogilvy Public Relations Worldwide provides communication consulting to biotechnology companies. The Holmes Report has named Ogilvy Public Relations Worldwide 2003 International Agency of the Year; marking the fourth consecutive year the firm has been awarded “Agency of the Year.” Ogilvy Public Relations Worldwide is part of the WPP Group, the world’s largest marketing communications company (NASDAQ: WPPGY, www.wpp.com). For more information, visit our Web site at www.ogilvypr.com.